Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Research Articles, Behavioral/Cognitive

Hippocampal Threat Reactivity Interacts with Physiological Arousal to Predict PTSD Symptoms

Büşra Tanriverdi, David F. Gregory, Thomas M. Olino, Timothy D. Ely, Nathaniel G. Harnett, Sanne J.H. van Rooij, Lauren A.M. Lebois, Antonia V. Seligowski, Tanja Jovanovic, Kerry J. Ressler, Stacey L. House, Francesca L. Beaudoin, Xinming An, Thomas C. Neylan, Gari D. Clifford, Sarah D. Linnstaedt, Laura T. Germine, Kenneth A. Bollen, Scott L. Rauch, John P. Haran, Alan B. Storrow, Christopher Lewandowski, Paul I. Musey, Phyllis L. Hendry, Sophia Sheikh, Christopher W. Jones, Brittany E. Punches, Michael C. Kurz, Meghan E. McGrath, Lauren A. Hudak, Jose L. Pascual, Mark J. Seamon, Elizabeth M. Datner, Claire Pearson, Robert M. Domeier, Niels K. Rathlev, Brian J. O'Neil, Leon D. Sanchez, Steven E. Bruce, Mark W. Miller, Robert H. Pietrzak, Jutta Joormann, Deanna M. Barch, Diego A. Pizzagalli, John F. Sheridan, Jordan W. Smoller, Steven E. Harte, James M. Elliott, Samuel A. McLean, Ronald C. Kessler, Karestan C. Koenen, Jennifer S. Stevens and Vishnu P. Murty
Journal of Neuroscience 24 August 2022, 42 (34) 6593-6604; DOI: https://doi.org/10.1523/JNEUROSCI.0911-21.2022
Büşra Tanriverdi
1Department of Psychology and Neuroscience, Temple University, Philadelphia, Pennsylvania 19121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David F. Gregory
1Department of Psychology and Neuroscience, Temple University, Philadelphia, Pennsylvania 19121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David F. Gregory
Thomas M. Olino
1Department of Psychology and Neuroscience, Temple University, Philadelphia, Pennsylvania 19121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy D. Ely
2Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30329
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Timothy D. Ely
Nathaniel G. Harnett
3Division of Depression and Anxiety, McLean Hospital, Belmont, Massachusetts 02478
4Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanne J.H. van Rooij
2Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30329
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren A.M. Lebois
3Division of Depression and Anxiety, McLean Hospital, Belmont, Massachusetts 02478
4Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonia V. Seligowski
3Division of Depression and Anxiety, McLean Hospital, Belmont, Massachusetts 02478
4Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanja Jovanovic
5Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Michigan 48202
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerry J. Ressler
3Division of Depression and Anxiety, McLean Hospital, Belmont, Massachusetts 02478
4Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kerry J. Ressler
Stacey L. House
6Department of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri 63110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca L. Beaudoin
7Department of Emergency Medicine & Department of Health Services, Policy, and Practice, Alpert Medical School of Brown University, Rhode Island Hospital, and Miriam Hospital, Providence, Rhode Island 02930
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinming An
8Institute for Trauma Recovery, Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27559
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas C. Neylan
9Departments of Psychiatry and Neurology, University of California San Francisco, San Francisco, California 94143
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gari D. Clifford
10Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, Georgia 30332
11Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia 30332
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah D. Linnstaedt
8Institute for Trauma Recovery, Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27559
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sarah D. Linnstaedt
Laura T. Germine
4Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115
12Institute for Technology in Psychiatry, McLean Hospital, Belmont, Massachusetts 02478
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth A. Bollen
13Department of Psychology and Neuroscience & Department of Sociology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27559
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott L. Rauch
4Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115
14Institute for Technology in Psychiatry/Department of Psychiatry, McLean Hospital, Belmont, Massachusetts 02478
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P. Haran
15Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01655
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan B. Storrow
16Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alan B. Storrow
Christopher Lewandowski
17Department of Emergency Medicine, Henry Ford Health System, Detroit, Michigan 48202
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul I. Musey
18Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phyllis L. Hendry
19Department of Emergency Medicine, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida 32209
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophia Sheikh
19Department of Emergency Medicine, University of Florida College of Medicine-Jacksonville, Jacksonville, Florida 32209
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher W. Jones
20Department of Emergency Medicine, Cooper Medical School of Rowan University, Camden, New Jersey 08103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany E. Punches
21Department of Emergency Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267
22College of Nursing, University of Cincinnati, Cincinnati, Ohio 45221
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael C. Kurz
23Department of Emergency Medicine, University of Alabama School of Medicine, Birmingham, Alabama 35294
24Department of Surgery, Division of Acute Care Surgery, University of Alabama School of Medicine, Birmingham, Alabama 35294
25Center for Injury Science, University of Alabama at Birmingham, Birmingham, Alabama 35294
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meghan E. McGrath
26Department of Emergency Medicine, Boston Medical Center, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lauren A. Hudak
27Department of Emergency Medicine, Emory University School of Medicine, Atlanta, Georgia 30329
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose L. Pascual
28Department of Surgery, Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania 19104
29Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Seamon
29Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104
30Department of Surgery, Division of Traumatology, Surgical Critical Care and Emergency Surgery, University of Pennsylvania, Philadelphia, Pennsylvania 19104
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth M. Datner
31Department of Emergency Medicine, Einstein Healthcare Network, Philadelphia, Pennsylvania 19141
32Department of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Pearson
33Department of Emergency Medicine, Wayne State University, Detroit, Michigan 48202
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claire Pearson
Robert M. Domeier
34Department of Emergency Medicine, Saint Joseph Mercy Hospital, Ypsilanti, Michigan 48197
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niels K. Rathlev
35Department of Emergency Medicine, University of Massachusetts Medical School-Baystate, Springfield, Massachusetts 01107
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. O'Neil
33Department of Emergency Medicine, Wayne State University, Detroit, Michigan 48202
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leon D. Sanchez
36Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215
37Department of Emergency Medicine, Harvard Medical School, Boston, Massachusetts 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven E. Bruce
38Department of Psychological Sciences, University of Missouri-St. Louis, St. Louis, Missouri 63121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark W. Miller
39National Center for PTSD, Behavioral Science Division, VA Boston Healthcare System, Boston, Massachusetts 02130
40Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts 02118
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert H. Pietrzak
41National Center for PTSD, Clinical Neurosciences Division, VA Connecticut Healthcare System, West Haven, Connecticut 06516
42Department of Psychiatry, Yale School of Medicine, West Haven, Connecticut 06510
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jutta Joormann
43Department of Psychology, Yale University, West Haven, Connecticut 06520
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deanna M. Barch
44Department of Psychological & Brain Sciences, Washington University in St. Louis, St. Louis, Missouri 63130
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Deanna M. Barch
Diego A. Pizzagalli
3Division of Depression and Anxiety, McLean Hospital, Belmont, Massachusetts 02478
4Department of Psychiatry, Harvard Medical School, Boston, Massachusetts 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diego A. Pizzagalli
John F. Sheridan
45Department of Biosciences, Ohio State University Wexner Medical Center, Columbus, Ohio 43210
46Institute for Behavioral Medicine Research, Ohio State University Wexner Medical Center, Columbus, Ohio 43211
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan W. Smoller
47Department of Psychiatry, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts 02114
48Stanley Center for Psychiatric Research, Broad Institute, Cambridge, Massachusetts 02142
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven E. Harte
49Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, Michigan 48109
50Department of Internal Medicine-Rheumatology, University of Michigan Medical School, Ann Arbor, Michigan 48109
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James M. Elliott
51Kolling Institute of Medical Research, University of Sydney, St Leonards, New South Wales 2065, Australia
52Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales 2006, Australia
53Physical Therapy & Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60208
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel A. McLean
8Institute for Trauma Recovery, Department of Anesthesiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27559
54Department of Emergency Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27559
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samuel A. McLean
Ronald C. Kessler
55Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ronald C. Kessler
Karestan C. Koenen
56Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts 02115
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer S. Stevens
2Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30329
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vishnu P. Murty
1Department of Psychology and Neuroscience, Temple University, Philadelphia, Pennsylvania 19121
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vishnu P. Murty
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Hippo campal impairments are reliably associated with post-traumatic stress disorder (PTSD); however, little research has characterized how increased threat sensitivity may interact with arousal responses to alter hippocampal reactivity, and further how these interactions relate to the sequelae of trauma-related symptoms. In a sample of individuals recently exposed to trauma (N = 116, 76 female), we found that PTSD symptoms at 2 weeks were associated with decreased hippocampal responses to threat as assessed with fMRI. Further, the relationship between hippocampal threat sensitivity and PTSD symptomology only emerged in individuals who showed transient, high threat-related arousal, as assayed by an independently collected measure of fear potentiated startle. Collectively, our finding suggests that development of PTSD is associated with threat-related decreases in hippocampal function because of increases in fear-potentiated arousal.

SIGNIFICANCE STATEMENT Alterations in hippocampal function linked to threat-related arousal are reliably associated with post-traumatic stress disorder (PTSD); however, how these alterations relate to the sequelae of trauma-related symptoms is unknown. Prior models based on nontrauma samples suggest that arousal may impact hippocampal neurophysiology leading to maladaptive behavior. Here we show that decreased hippocampal threat sensitivity interacts with fear-potentiated startle to predict PTSD symptoms. Specifically, individuals with high fear-potentiated startle and low, transient hippocampal threat sensitivity showed the greatest PTSD symptomology. These findings bridge literatures of threat-related arousal and hippocampal function to better understand PTSD risk.

  • arousal
  • fear
  • fMRI
  • hippocampus
  • trauma

Introduction

Threat is known to alter hippocampal function, a region critically implicated in supporting memory (Eichenbaum, 2001). Whereas moderate threat increases hippocampal sensitivity (Joëls et al., 2006), excessive threat impairs hippocampal function (Kim and Diamond, 2002; McEwen, 2007; Henckens et al., 2009; Schwabe and Wolf, 2012; Bisby and Burgess, 2013, 2017). In post-traumatic stress disorder (PTSD), decreased hippocampal engagement propagates traumatic memories (Hayes et al., 2011) and impairs discrimination between danger and safety signals, leading to the overgeneralization of fear (Besnard and Sahay, 2016; Asok et al., 2019), which underlies PTSD (e.g., Hayes et al., 2011). Further, lower hippocampal engagement during inhibitory tasks has been associated with PTSD (van Rooij et al., 2016; van Rooij, 2018). However, contradictory evidence shows increased hippocampal engagement during trauma-related memory and imagery in individuals with PTSD (Bremner et al., 2003; Tural et al., 2018). These inconsistencies may result from the functional demands placed on the hippocampus (HPC; threat vs safety detection) and the neuromodulatory profile in which these demands occur (high vs low arousal). Here, we characterize the relationship among hippocampal function, threat-related arousal, and PTSD symptomology in a large sample of trauma-exposed individuals.

We previously developed a model of how threat-related arousal alters hippocampal function, biasing information processing away from HPC to other learning structures because of arousal-mediated norepinephrine (NE) engagement (Murty and Adcock, 2017; Clewett and Murty, 2019). Specifically, we predict that threat-related arousal disrupts behavioral and neural indices of hippocampal function. Thus, this model posits that an individual's threat sensitivity, including heightened defensive arousal, can determine downstream impairments in hippocampal function and associated symptoms (Murty and Adcock, 2017).

Many aspects of PTSD fall within this theoretical framework. Threat-predictive behaviors, such as fear-potentiated startle (FPS) responses to danger and safety cues, are heightened in PTSD (Grillon and Morgan, 1999; Grillon and Baas, 2003; Glover et al., 2011; Norrholm and Jovanovic, 2018), and are associated with increased NE engagement (Yehuda et al., 1996). Patients with PTSD (1) show greater arousal in response to cues of both danger and safety (Jovanovic et al., 2010, 2012; Shin and Liberzon, 2010; Pitman et al., 2012; Briscione et al., 2014); (2) fail to inhibit fear responses during fear extinction (Milad et al., 2009; Jovanovic et al., 2010, 2012; Maren and Holmes, 2016; Cacciaglia et al., 2017; Maeng and Milad, 2017); and (3) overgeneralize fear responses (Hoffmann et al., 2014). Yet these profiles of threat sensitivity have yet to be directly related to hippocampal function. However, our model predicts that these increases in arousal may divert information processing resources away from the HPC, leading to PTSD risk.

In the current study, we extend our model to trauma-related behavioral impairment by characterizing hippocampal dysfunction in relation to heightened arousal and PTSD symptom severity in trauma-exposed participants. We operationalize hippocampal threat sensitivity as responses to fearful versus neutral face stimuli with functional imaging, and arousal as FPS responses to learned danger and safety cues. We also make a distinction between the anterior HPC (aHPC) and posterior HPC (pHPC) portions of the HPC, given aHPC is reportedly more responsive during fear learning and trauma-related arousal (Bannerman et al., 2004; Dolcos et al., 2004; Murty et al., 2010; Hayes et al., 2011; Strange et al., 2014; Abdallah et al., 2017). Our main analyses characterize transient HPC responses reflecting initial threat sensitivity in this region, but we also conduct exploratory analyses reflecting more sustained activity indicating contextual processing. We hypothesized that (1) reductions in HPC threat sensitivity, specifically the aHPC, will predict PTSD symptom severity in trauma-exposed individuals and (2) associations between HPC-threat sensitivity and PTSD symptoms will be mediated by FPS responses.

Materials and Methods

Participants

Participants were recruited from United States emergency departments (EDs) as part of a multisite longitudinal study: Advancing Understanding of RecOvery afteR traumA (AURORA; U01MH110925) (McLean et al., 2020). Twenty-two EDs within the Northeast, Southern, mid-Atlantic, or Midwest regions of the United States enrolled patients in the ED within 72 h of trauma exposure. All participants were ages 18-75, able to speak and read English, oriented in time and place, physically able to use a smartphone, and possessed a smart phone for >1 year. Potential participants were excluded if they had a solid organ injury >Grade 1, significant hemorrhage, required a chest tube or general anesthesia, or were likely to be admitted for >72 h. MRI scans were collected between 2 and 3 weeks later (Mday = 18, SDday = 6, referred to as 2 week assessment from here on) at a laboratory visit which included MRI and psychophysiology at four hub sites: McLean Hospital, Emory University, Temple University, or Wayne State University. All participants gave written informed consent as approved by each study site's Institutional Review Board.

Data collection for the parent study is ongoing and released in specific data freezes. For the second large deep-phenotyping freeze of 202 participants, we focused analyses on using fMRI data during an emotional face processing task and startle data in a fear conditioning paradigm to predict concurrent and future PTSD symptoms (for the timeline of assessments, see Fig. 1). A total of 116 participants (age: mean = 35.19, SD = 12.51 years, 76 female) were included after excluding for missing PTSD data, and fMRI preprocessing (see fMRI preprocessing) in the release. Participant demographics and psychometric averages are reported in Table 1.

View this table:
  • View inline
  • View popup
Table 1.

Demographic and clinical characteristics

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Experimental timeline. Participants were recruited from EDs after exposure to trauma. Trauma symptoms were assessed 2 weeks, 8 weeks, and 3 months after trauma using PCL-5. As part of the 2 week assessments, participants also completed a fear conditioning task, and a face viewing task in the MRI scanner. During fear conditioning, colored shapes were either reinforced (CS+) or not reinforced (CS–) with air blast, and FPS responses to the CS+ and CS– stimuli were measured. In the fMRI study, participants passively viewed fearful and neutral faces in the scanner.

Psychometric assessments

PTSD symptoms were assessed using the PTSD Symptom Checklist for DSM-5 (PCL-5). The PCL-5 is a 20 item self-report questionnaire assessing the presence and severity of various post-traumatic stress symptoms (Weathers et al., 2013). Participants rated symptoms on a scale of 0 (not at all) to 4 (extremely) for the severity of each symptom. A raw total score was computed from summing the individual items and converted to a T-score, reflecting a more general score. Our main analyses focused on the symptom severity at 2 weeks. In an exploratory analysis, we also tested how PTSD symptoms changed from 2 weeks to 8 weeks, and to 3 months after trauma exposure (Fig. 1).

Acquisition and analysis of FPS

Fear conditioning was assessed with a fear-potentiated startle experimental paradigm used successfully in adult trauma populations (Glover et al., 2011; Norrholm et al., 2011). Participants completed this task during the laboratory visit for the MRI scans within the 2 weeks of their trauma exposure (Fig. 1). Participants were seated ∼3 feet from a computer screen and asked to remain still and watch the monitor. The protocol consisted of a habituation, acquisition, and extinction phase, all on the same day, lasting a total of 45-60 min. The habituation phase included four trials of each type: startle noise alone (NA); a conditioned stimulus (CS), which would be paired with the unconditioned stimulus (US) during acquisition (CS+); and a CS, which would not be reinforced during acquisition (CS–). The acquisition phase followed habituation and contained three blocks with 12 trials each (36 total acquisition trials). The US was an aversive 250 ms air blast with an intensity of 140 psi directed at the larynx. Both CSs were colored shapes presented on the monitor in front of the participant using Superlab presentation software (Cedrus) for 6 s before the startle probe. The CS+ coterminated with the US 0.5 s after the presentation of the startle stimulus. The shape and color of the CS– and CS+ were counterbalanced across subjects. The CS+ was reinforced with the air blast on 100% of the acquisition trials. The air blast was emitted by a compressed air tank attached to polyethylene tubing and controlled by a solenoid switch. This US has been used in several of our previous studies and consistently produces robust FPS (Jovanovic et al., 2005; Norrholm et al., 2011). The extinction phase occurred 10 min after acquisition and consisted of four blocks of four trials each (NA, CS+, CS–) for a total of 16 trials of each type. During extinction, the CS+ was no longer paired with the air blast. In all phases, the intertrial intervals were randomized to be 9-22 s in duration.

The acoustic startle response data were acquired using the EMG Bionomadix module of the Biopac MP160 for Windows (Biopac Systems). Participants were screened for hearing impairment with an audiometer (Grason-Stadler, Model GS1710), and were required to hear tones ranging from 250 Hz to 4000 Hz above 30 dB. The eyeblink component of the acoustic startle response was measured by EMG recordings of the right orbicularis oculi muscle with two 5 mm Ag/AgCl electrodes. One electrode was positioned 1 cm below the pupil of the right eye, and the other was placed 1 cm below the lateral canthus. Impedance levels were <6 kilo-ohms for each participant. The startle probe was a 108-dB [A] SPL, 40 ms burst of broadband noise, delivered binaurally through headphones.

EMG data were sampled at 1000 Hz, and the acquired data were filtered with low- and high-frequency cutoffs at 28 and 500 Hz in MindWare software (MindWare Technologies) and exported for statistical analyses. The maximum amplitude of the eyeblink muscle contraction 20-200 ms after presentation of the startle probe was used as a measure of the acoustic startle response. FPS was calculated as a percent potentiation: First, a difference score is calculated by subtracting average startle magnitude to the NA trials from average startle magnitude to the CS+ (danger signal) and CS– (safety signal). The difference score was then divided by the startle magnitude to NA trials, and finally multiplied by 100. Percent potentiation scores were used because they have been shown to take into account the variability in individual animals (Walker and Davis, 2002). We also calculated an FPS difference score by subtracting FPS to CS– from FPS to CS+, highlighting participants' ability to discriminate between danger and safety.

MRI data acquisition

Before scanning, participants were screened for MR contraindications or other exclusion criteria. Female participants and participants who were potentially childbearing completed a pregnancy test before entering the MR environment. MRI scans were completed on 3T Siemens scanners at each site. Scan sequences were largely harmonized between imaging sites with some variability in sequence parameters because of hardware differences (for overview of all imaging parameters, see Table 2). Following familiarization with the MR environment, participants completed first the T1-weighted anatomic imaging, and then the fMRI. T1-weighted images were used for coregistration (see Preprocessing). Below we report on the passive viewing of fearful faces during fMRI scan (for the details of all MRI scans not reported here, see McLean et al., 2020).

View this table:
  • View inline
  • View popup
Table 2.

MRI scan sequence parameters by site

fMRI task design

Integral to the assessment of neural circuitry related to PTSD in the peritraumatic and-post-traumatic periods is the inclusion of stimuli and tasks to probe various cognitive and affective processes. Three separate tasks were chosen for the AURORA study; the neural substrates activated within each task have been highly replicated and are in line with the National Institutes of Health Research Domain Criteria constructs (Insel et al., 2010). Participants completed passive viewing of fearful faces (Stevens et al., 2013), a go/no-go task (Jovanovic et al., 2013), and a card-guessing (reward) task (Delgado et al., 2000).

We report on the fearful face processing task (Stevens et al., 2013). This task has been used in several PTSD studies and has consistently demonstrated greater activation of the amygdala to fearful, compared with neutral, faces (Shin et al., 2005; Stevens et al., 2013; Kim et al., 2019). Participants viewed alternating blocks of either neutral or fearful faces of white race from the Ekman and Friesen faces library (Ekman and Friesen, 1976). Before the task participants were told that they will be shown a series of faces and instructed to “be alert and pay attention to the faces.” Blocks of fearful and neutral stimuli were sequentially presented with the order of fearful and neutral blocks counterbalanced across participants (15 blocks each). In each block, a total of eight faces (four male, four female) were presented for 500 ms each with a 500 ms fixation cross presented after each face. Every 10th block, participants received a 10,000 ms fixation cross as a “rest period” and instructed to “relax and look at the screen” (Kim et al., 2019). No behavioral responses were collected from participants during this task to minimize artifacts because of other neural processes not related to processing the visual stimulus.

MRI data conversion and quality control

DICOM images were converted to NIFTI format with Brain Imaging Data Structure nomenclature using dcm2niix (Li et al., 2016) and were visually inspected for conversion errors and data exclusion criteria (e.g., signal drop-out from Falx calcification, anatomic abnormalities). Further quality control was achieved by running the MRIQC pipeline (version 0.10.4 in a Docker container) (Esteban et al., 2017) on the structural and functional images.

fMRI preprocessing

fMRI preprocessing was performed with FSL 6.0.1. (Jenkinson et al., 2012). First, the T1-weighted anatomic image was skull-stripped using the Brain Extraction Tool. This image was used to assist in spatial normalization processes detailed below. Brain tissue segmentation of white matter, gray matter, and CSF was performed on the brain extracted T1-weighted images using FAST. These segmentations were used to extract time series from the white matter and CSF for reduction of noise in our preprocessing stream. fMRI preprocessing was completed using the fMRI Expert Analysis Tool version as implemented in FSL 6.0.1. using a pipeline designed to minimize the effects of head motion (Murty et al., 2018). This included simultaneous head motion correction, and nonlinear warping to the MNI space, but no temporal or spatial filtering.

Following preprocessing, we ran a GLM, where the onset of fearful and neutral blocks of faces were modeled as separate regressors, and were convolved with a double-γ HRF as an event-related response capturing the block onset. Six head-motion parameters, and their first derivatives, and time series extracted from CSF and white matter were added as covariates to the model to reduce noise. For our exploratory analysis of sustained responses, a second GLM was run with the additional regressors to model the entire duration (8 s) for the fearful and neutral blocks in addition to the transient on-set block (i.e., to model the sustained activity). The GLMs were run using fMRI Expert Analysis Tool version 6.0 as implemented in FSL 6.0.3. First level contrasts of fearful>baseline, neutral>baseline, and fearful>neutral contrasts were estimated in our ROIs, separately for each hemisphere.

Defining ROIs

For all of our analyses, we focused on the HPC as our a priori ROI. The HPC was identified in standard space with a probabilistic atlas thresholded at 50% from the Harvard-Oxford probabilistic subcortical atlas as implemented by FSL (Desikan et al., 2006) (https://neurovault.org/collections/262/). We then divided the original HPC along its long axis into three tertiles and used the anterior and posterior tertiles as our anterior and pHPC ROIs (Murty et al., 2017). We did not use the middle tertile in this analysis as signals from this region have been shown to be a mixture of anterior versus posterior hippocampal processing (Kerr et al., 2007; Poppenk et al., 2013). For each participant, all ROIs were transformed into subject-specific space using the inverse of the parameters estimated during normalization. Individual ROIs were created in the subject-specific for both anatomic and functional spaces. In cases where ROIs in the subject space had overlapping voxels, such voxels were included in the ROIs in which they had the highest probability of inclusion. Each ROI was manually inspected by a trained research assistant.

Data analysis

We first resampled all of the preprocessed functional data and anatomic ROIs into 2.0 mm isotropic voxels in MNI space. For the univariate analyses, we extracted the event-specific mean activity in all our ROIs for the task phase, acquiring z scores for the following contrasts: (1) activity when a fearful face was viewed was compared with the baseline at task phase (fearful>baseline), (2) activity when a neutral face was viewed was compared with the baseline at task phase (neutral>baseline), and finally, (3) activity when a fearful face was viewed was compared with the activity when a neutral face was viewed (fearful>neutral). All analyses were completed for the right and left hemispheres separately.

Secondarily, we tested the effect of emotion on the activity of the left aHPC, right aHPC, left pHPC, and right pHPC in four separate models. Then, we assessed whether fear-related activity (fearful>neutral) predicted the participants' PTSD symptom severity at 2 weeks. To do so, we tested four separate models where the 2 weeks PTSD symptoms were predicted by the activity in left aHPC, right aHPC, left pHPC, and right pHPC. Across all four models, significance was set at p < 0.05 (uncorrected), while Bonferroni corrections for multiple comparisons were set at p < 0.0125. Importantly, we tested two additional models, which included activity from both left and right hemispheres as covariates (separately for aHPC and pHPC). Then for each subregion, we tested whether the coefficients differed between left and right to test any effects of laterality.

Next, we tested whether threat-related activity in the HPC relates to arousal responses. Twenty-two subjects were removed from these models because of missing startle data (N = 95, 62 female). We first tested whether the fear acquisition elicited the intended effects, comparing participants' FPS responses to CS+ (danger signal) and CS– stimuli (safety signal). Next, we tested whether FPS is predicted by the threat-related activity in the HPC. Finally, we tested whether startle responses interacted with fear-related hippocampal reactivity in predicting the PTSD symptoms at 2 weeks after trauma. Importantly, we tested this assumption only in the regions whose activity yielded significant effects on the PTSD symptoms at 2 weeks (for more details, see Results). Therefore, we tested a total of two models here, with significance set at p < 0.05 (uncorrected) and Bonferroni correction set at p < 0.025.

We next tested a time-based hypothesis that hippocampal threat sensitivity, together with physiological threat sensitivity, would predict PTSD symptom change across the follow-up assessments (8 weeks and 3 months after trauma). To that end, we first tested a mixed-effects model with a two-way interaction between threat-related activity and time (2 weeks, 8 weeks, and 3 months), separately in aHPC and pHPC. We then tested a second mixed-effects model with a three-way interaction model between threat-related hippocampal activity, FPS responses, and time, separately in anterior and posterior subregions. Across all four models, significance was set at p < 0.05 (uncorrected), while Bonferroni corrections for multiple comparisons were set at p < 0.0125.

We next conducted an exploratory analysis. Specifically, we tested whether the sustained hippocampal activity related to PTSD symptomatology differently than transient activity. To that end, we repeated the analyses above using the activity extracted from the fearful > neutral contrast from the GLM where sustained activity was modeled. Therefore, we tested four initial models where PTSD symptoms at 2 weeks were predicted by the sustained HPC activity. The significance was set at p < 0.05 (uncorrected) and Bonferroni correction set at p < 0.0125 for these models. For the regions with significant effects on PTSD outcome that survived the Bonferroni correction, we then proceeded with the additional tests with the interaction models (FPS difference by hippocampal activity). This resulted in two additional tests, for which the significance set at p < 0.05 (uncorrected) and Bonferroni correction set at p < 0.025.

The unstandardized β coefficients are reported for all our significant results. All analyses were performed using R software (R package version 3.4.1) using the anova (the stats library), glm (the stats library), glmer (the lme4 library), linearHypothesis (the car library), and simple_slopes (the reghelper library) functions depending on the test. Finally, regression models predicting PTSD symptoms were tested using a Poisson distribution (family = Poisson (link= “log”)) since the symptom distribution was positively skewed. Age, gender, and scanner type (to control potential effects of different scanners on the hippocampal signal) were added in all of the models as covariates. Finally, all continuous variables were standardized before testing the regression models. Analysis scripts are available on request.

Results

HPC does not differentiate between fearful and neutral faces

Four separate one-way ANOVAs testing the effect of emotion (fearful, neutral) on the neural activity were run in the left aHPC, right aHPC, left pHPC, and right pHPC. The models did not reveal any significant main effect of emotion (left anterior: F(2,230) = 0.01, p = 0.8; right anterior: F(2,230) = 0.001, p = 0.9; left anterior: F(2,230) = 1.2, p = 0.3; right anterior: F(2,230) = 0.06, p = 0.8), suggesting that HPC does not differentiate between fearful and neutral faces.

Decreased transient left hippocampal fear-related activity predicts PTSD symptoms

Threat-related transient activity in left aHPC (left: β = −0.08, SE = 0.02, p < 0.0001) and left pHPC (β = −0.09, SE = 0.02, p < 0.0001) was associated with PTSD symptom severity at 2 weeks (Fig. 2; Table 3), such that relatively less threat-related reactivity in the HPC the greater their 2 week PTSD symptom. All of the reported models with a significant effect survived Bonferroni correction (padjusted = 0.0125). However, right HPC was not a significant predictor of PTSD symptoms at 2 weeks (anterior: p = 0.22; posterior: p = 0.05); thus, we did not test the following FPS-related models in right aHPC and pHPC.

View this table:
  • View inline
  • View popup
Table 3.

Predicting PTSD Symptoms at 2-Weeks from Transient Hippocampal Threat (F>N) Reactivity and Fear-Potentiated Startle (FPS) Difference between Danger (CS+) and Safety (CS−)

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Reduced threat-related transient activity in hippocampus predicts PTSD severity. Increased threat-related transient activity in left aHPC and left pHPC, as measured by the fearful > neutral face image contrasts, predicted lower PTSD symptom severity at 2 weeks, concurrent with the timing of the fMRI scan. The effects are shown as follows: (A) left aHPC; (B) left pHPC.

It is important to note that left aHPC and left pHPC activity was correlated (r(114) = 0.21, p = 0.03); however, the low correlation between the two subregions emphasizes the relative orthogonality of the aHPC and pHPC activity in predicting PTSD symptom severity. Finally, comparing coefficients from left and right hemisphere for both hippocampal subregions revealed that the association between hippocampal activity and PTSD symptom severity was stronger in the left than right hemisphere (anterior: χ2(109) = 10.69, p = 0.001; posterior: χ2(109) = 13.4, p = 0.0003).

Increased FPS responses during fear acquisition predict PTSD symptoms

Participants had greater FPS response to the CS+ (danger) compared with the CS– (safety) during fear acquisition (t(93) = 3.4, p = 0.001), suggesting that they learned to discriminate between the danger and safety cues. Therefore, we focused on the FPS difference between danger and safety cues as our main predictor in the startle models. To that end, we first tested whether FPS difference was associated with the PTSD symptoms at 2 weeks. The results revealed that increased FPS difference was associated with higher PTSD symptoms (β = 0.07, SE = 0.02, p = 0.0002).

Fear-related transient activity in the HPC and startle responses during fear acquisition interactions predict PTSD symptoms

The models testing whether threat-related activity in the HPC was associated with FPS responses did not reveal any significant relationship (left anterior: F(3,90) = 0.7, p = 0.6; left posterior: F(3,90) = 0.5, p = 0.7). Critically, we found that significant interactions between transient threat-related hippocampal activity and FPS difference predicted 2 week PTSD symptoms (left anterior: β = −0.04, SE = 0.02, p = 0.017; left posterior: β = −0.09, SE = 0.03, p = 0.001). Results from both left aHPC and left pHPC survived Bonferroni corrections (padjusted = 0.025). To determine whether these findings generalized to alternative approaches to estimating FPS, we separately calculated FPS by using a residualization approach (i.e., using the residual FPS to CS+ and CS– after regressing out the average startle magnitude to the NA trials). This approach yielded results similar to HPC × FPS interactions in the posterior, but not anterior, HPC (anterior: β = 0.007, p = 0.63; posterior: β = 0.08, p = 0.004), which suggests that the reported FPS-related PTSD outcomes in the pHPC are specific to threat-related arousal instead of individual differences in baseline startle responses.

Simple slopes analyses revealed that the inverse relationship between transient left anterior hippocampal threat reactivity and PTSD symptoms at 2 weeks was stronger for high (+1 SD) FPS differentiation (β = −0.07, SE = 0.03, t = −2.8, p = 0.005). Moreover, the relationship between transient left posterior hippocampal threat reactivity and PTSD symptoms was stronger for both mean and high (+1 SD) FPS differentiation (mean: β = −0.06, SE = 0.02, t = −2.82, p = 0.005; high: β = 0.15, SE = 0.04, t = −3.99, p < 0.0001) (Fig. 3). These effects suggest that individuals with higher FPS differentiation and lower transient hippocampal reactivity to threat report higher PTSD symptoms.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

FPS interacts with transient hippocampal threat reactivity in predicting PTSD at 2 weeks. Increased FPS differentiation between danger (CS+) and safety (CS–) cues had a significant effect on the inverse relationship between the increased hippocampal threat reactivity and lower PTSD symptoms at 2 weeks in (A) left aHPC and (B) left pHPC.

Independent contributions of fearful and neutral hippocampal reactivity to PTSD symptoms

To better decompose the component effects guiding the relationships above, we next tested whether our hippocampal effects were driven by changes in the HPC activity specific to the fearful (fearful>baseline) or neutral (neutral>baseline) faces. The fearful-only analyses revealed that decreased transient reactivity in left aHPC and pHPC was associated with greater PTSD symptoms at 2 weeks (anterior: β = −0.06, SE = 0.02, p < 0.0004; posterior: β = −0.04, SE = 0.02, p = 0.015, both effects survive Bonferroni adjustments at padjusted = 0.025). However, there were no significant interactions between the transient fearful-only hippocampal activity and FPS difference in predicting PTSD symptoms at 2 weeks.

On the other hand, increased transient neutral-only activity in left pHPC was associated with increased PTSD symptoms at 2 weeks (β = 0.04, SE = 0.02, p = 0.038, albeit it did not survive Bonferroni corrections at p = 0.025). Importantly, the neutral-only activity in left pHPC significantly interacted with FPS difference score in predicting PTSD symptoms at 2 weeks (β = 0.06, SE = 0.03, p = 0.02). Simple slopes analysis revealed that this association was significant at the lower end of the FPS difference (−1 SD, p = 0.045) and at the moderate (mean; p = 0.003) and higher (+1 SD; p < 0.0001) left posterior hippocampal activity to neutral faces. These results suggest that decreased transient activity to fearful stimuli and increased transient activity to neutral stimuli in HPC both contribute to increased PTSD symptomatology.

PTSD symptom change across time

We took a growth modeling approach to analyze whether the symptom change from 2 weeks to 8 weeks and 3 months follow-ups is predicted by hippocampal threat reactivity and/or FPS differentiation. For these analyses, we focused on the left aHPC and left pHPC given their significant role in 2 week PTSD outcomes. Analyses revealed a main effect of time (Table 4), such that PTSD symptoms decreased from 2 weeks to 8 weeks and 2 weeks to 3 months follow-up assessments. However, there were no significant interactions between time, hippocampal threat reactivity, and FPS differentiation (Table 4).

View this table:
  • View inline
  • View popup
Table 4.

Predicting PTSD symptom change across time from transient hippocampal threat reactivity and FPS differentiation between danger (CS+) and safety (CS–)

Age, gender, and scanner effects on PTSD

Age, gender, and scanner type were included as covariates in all models. In all the 2 weeks PTSD models reported above, gender was a significant predictor of PTSD symptoms (Table 3) such that female subjects reported higher PTSD symptom score compared with male participants. Age was also a significant predictor of PTSD symptoms in the simple 2 weeks models, but this effect was no longer evident when the FPS difference was added to the models as an interaction term (Table 3). Finally, including the scanner type as a covariate ensured that the reported significant hippocampal effects were not influenced by the scanner related differences across the study sites.

Sustained fear-related activity in the HPC predicts increased PTSD symptoms

In a set of exploratory analyses, we next tested whether sustained fear-related hippocampal activity relates to PTSD symptoms differently than the transient activity. Notably, these analyses included both sustained and transient activity within the same fMRI model when estimating single-subject parameters, highlighting independent contributions of sustained activity. The results revealed that increased sustained fear-related activity in left and right posterior (left: β = 0.05, SE = 0.02, t = 2.69, p = 0.007; right: β = 0.06, SE = 0.02, t = 3.17, p = 0.002) HPC was associated with increased PTSD symptoms at 2 weeks (Fig. 4A,B). These results suggest that sustained posterior hippocampal reactivity to fear-related information relates to higher PTSD symptomatology (Table 5). Importantly, interactions between the sustained pHPC and FPS difference significantly predicted PTSD symptoms at 2 weeks (left: β = 0.04, SE = 0.02, t = 2.27, p = 0.024; right: β = 0.04, SE = 0.02, t = 2.45, p = 0.015, both effects survive Bonferroni corrections at padjusted = 0.025) (Fig. 4C,D). Simple slopes analyses revealed that this interaction effect was stronger at the higher levels of FPS difference (+1 SD: p = 0.0007 in left posterior; p < 0.0001 in right posterior). Moreover, the interaction effects were also stronger for the moderate (mean: p < 0.0001 in left posterior; p < 0.0001 in right posterior) and higher levels of sustained pHPC activity (+1 SD: p < 0.0001 in left posterior; p < 0.0001 in right posterior). Accordingly, individuals with higher sustained fear-related activity in pHPC and higher FPS difference report higher PTSD symptoms at 2 weeks.

View this table:
  • View inline
  • View popup
Table 5.

Predicting PTSD symptoms at 2 weeks from sustained hippocampal threat reactivity and FPS differentiation between danger (CS+) and safety (CS–)

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Effects of sustained hippocampal activity. Increased sustained threat-related activity in (A) left pHPC and (B) right pHPC predicted higher PTSD symptoms at 2 weeks. Increased FPS differentiation between danger (CS+) and safety (CS–) cues had a significant effect on the relationship between the increased hippocampal threat reactivity and increased PTSD symptoms at 2 weeks in (C) left pHPC and (D) right pHPC.

Discussion

Heightened arousal because of threatening events alter hippocampal activity (Kim and Diamond, 2002; Henckens et al., 2009; Schwabe and Wolf, 2012; Bisby and Burgess, 2013, 2017), which has been suggested to strengthen traumatic memories and exacerbate symptoms (Hayes et al., 2011). Here, we assessed the relationship between threat sensitivity, hippocampal function, and PTSD symptomology in a group of individuals recently exposed to trauma (McLean et al., 2020).

We first showed that decreased transient hippocampal threat sensitivity was related to PTSD symptom severity at 2 weeks after trauma exposure. Specifically, we found that participants who showed reduced transient threat reactivity in left aHPC and left pHPC reported more severe PTSD symptoms. This is consistent with previous research that showed reduced left HPC activity in PTSD patients when remembering trauma-related memories (Bremner, 2001; Bremner et al., 2003; Hayes et al., 2011) or recently learned negative information (Bisby and Burgess, 2017). Relatedly, reduced hippocampal activation during a response inhibition task has also been associated with increased PTSD symptoms in chronically traumatized individuals (van Rooij et al., 2016; van Rooij and Jovanovic, 2019), and predicted future PTSD symptoms in recently traumatized civilians (van Rooij et al., 2018). Together with these earlier findings, our study supports an account of intact hippocampal function playing a role in trauma resilience (van Rooij et al., 2021).

An important distinction between our findings and the previous research, however, is that previous research has shown that the association between the hippocampal dysfunction and PTSD was driven by the anterior portion of the HPC (Dickie et al., 2011; Hayes et al., 2011; Abdallah et al., 2017), a region that is often implicated in fear learning (Kjelstrup et al., 2002; Bannerman et al., 2004; Murty et al., 2010; Strange et al., 2014). However, we did not find a functional distinction between anterior and posterior portions of the HPC in predicting PTSD symptom severity, and our pHPC results were more robust to characterizing interactions with FPS in predicting PTSD symptoms. Moreover, albeit low, the activity in aHPC and pHPC was correlated in the current sample. Therefore, our results are more in line with the results of Lazarov et al. (2017), who recently showed that the functional distinction between aHPC and pHPC in their connectivity to regions in the default mode network (e.g., ventromedial PFC, precuneus, and posterior cingulate cortex), which are often implicated in PTSD patients, is eliminated in individuals with PTSD but not in trauma-exposed controls.

Our findings suggest a complex role of the HPC in threat sensitivity since it is highly sensitive to threatening stimuli after traumatic experiences. This heightened hippocampal sensitivity protects the individual from developing severe symptoms of PTSD, but only to the extent that it can process the negative information. We found that the relationship between hippocampal threat reactivity and PTSD symptom severity is modulated impaired ability to differentiate threat from safety (CS–). Specifically, our data demonstrated greater threat anticipation, as evidenced by the greater differentiation between FPS responses to CS+ and to CS–, was associated with lower reactivity in the left HPC. Moreover, this interaction between the reduced hippocampal reactivity and greater threat anticipation was linked with PTSD symptom severity at 2 weeks after trauma. Although previous research has established an association between reduced hippocampal activity and arousal symptoms of PTSD (Hayes et al., 2011), and between an impairment in delineating danger and safety cues and the development of PTSD (Jovanovic et al., 2010, 2012; Shin and Liberzon, 2010; Pitman et al., 2012; Briscione et al., 2014; Maeng and Milad, 2017), our results are unique in demonstrating that the same individuals who are highly reactive to threat cues also show impaired hippocampal engagement in the processing of threat cues, which is associated with PTSD symptom severity.

These findings may be surprising in the context of the prior PTSD literature, but our results are consistent with our recent model detailing arousal-related impairments in hippocampal function. Our model suggested that threat-related arousal impairs hippocampal function, biasing information processing away from the HPC to other learning structures, particularly when arousal-mediated systems, such as the NE system, are engaged (Clewett and Murty, 2019). Critically, PTSD studies have shown increased NE release in response to stress (for review, see Bremner, 2006), which may bias hippocampal threat reactivity. Given this evidence, we conclude that physiological arousal, a putative marker of the NE system, represents an important individual difference measure predicting whether the HPC will propagate or mitigate PTSD symptoms.

In a set of exploratory analyses, we also explored the relationship of more sustained hippocampal responses to threat and how they relate to PTSD symptoms. Specifically, we found unlike transient threat processing in the HPC, increased sustained engagement of the HPC in response to threatening stimuli positively predicted PTSD symptoms. These effects were even more pronounced in individuals who showed greater differentiation between threat and safety cues as measured by FPS. The opposing directions of these sustained responses compared with transient responses suggest that differential mechanisms may be at play when considering fast, event-evoked responses and more prolonged, sustained responses. Critically, the HPC has been shown to subserve multiple roles, including subserving the formation and retrieval of episodic memories (Eichenbaum, 2001), but also regulating stress responses that underlie hyper-salience and defensive behaviors (Herman et al., 2016; Jimenez et al., 2018; Goldfarb et al., 2020). While highly speculative, we suggest that the more transient responses in the HPC reflects more adaptive forms of memory encoding that can protect individuals from developing PTSD symptoms, whereas the more sustained responses may reflect sustained signals that propagate HPA-axis engagement, leading to greater susceptibility to the damaging effects of trauma. However, more empirical work that includes explicit, dynamic measures of episodic memory formation and hyper-salience are needed to confirm these hypotheses.

The current study had a few features that limited our ability to fully interpret our findings, that should be addressed in future work. First, our fearful face processing task did not include dynamic assays of behavior, such as eye-tracking, subsequent memory, or physiological arousal, to help us integrate our neural findings with behavioral outcomes. Including more behavioral variables related to real-time assessments of hippocampal threat sensitivity could provide clear relationships to PTSD symptoms. Second, all participants in our study were exposed to trauma in recent history. Thus, our study lacks the baseline of a normative, non–trauma-exposed cohort, which could help us determine whether individuals with low PTSD reflect signals of resilience and/or compensation. Third, our current sample of trauma participants consisted mainly of individuals in recent automobile accidents, with relatively low sampling of other forms of trauma. Thus, the current dataset was unable to disambiguate how different forms of trauma relate to PTSD symptoms, which has important implications for the development of tailored therapeutics.

Together, our findings are consistent with a novel model of the involvement of the HPC in mediating PTSD symptomology. Specifically, we propose that decreased threat sensitivity in the HPC, a structure known to support safety learning, contributes to both concurrent PTSD symptoms as well as the propagation of these symptoms into the future. However, our model further specifies that an important mediator of this relationship is state-dependent physiological arousal. Thus, physiological arousal may divert information processing away from the HPC during threat learning, yielding vulnerability and risk. Future studies are warranted linking engagement of the hippocampal system to memory fragmentation and threat-related memory, as prior work has specified this relationship in normative populations.

Footnotes

  • This work was supported by National Institute of Mental Health U01MH110925 to K.J.R., K00MH119603 to N.G.H., K01MH118467 to L.A.M.L., the U.S. Army Medical Research and Material Command, The One Mind Foundation, and The Mayday Fund. Verily Life Sciences and Mindstrong Health provided some of the hardware and software used to perform study assessments. Data and/or research tools used in the preparation of this manuscript were obtained from the National Institute of Mental Health Data Archive. The National Institute of Mental Health Data Archive is a collaborative informatics system created by the National Institutes of Health to provide a national resource to support and accelerate research in mental health. This manuscript reflects the views of the authors and may not reflect the opinions or views of the National Institutes of Health or of the submitters submitting original data to the National Institute of Mental Health Data Archive. Support for title page creation and format was provided by AuthorArranger, a tool developed at the National Cancer Institute. We thank the trauma survivors participating in the AURORA Study. Their time and effort during a challenging period of their lives make our efforts to improve recovery for future trauma survivors possible.

  • K.J.R. has served on advisory boards for Takeda, Resilience Therapeutics, Janssen and Verily/Google. His research has been sponsored by Alkermes and Brainsway, and he has worked as a consultant for Alkermes. In the last 3 years, G.D.C. has received research funding from the National Science Foundation, National Institutes of Health, and LifeBell AI, and unrestricted donations from AliveCor, Amazon Research, the Center for Discovery, the Gordon and Betty Moore Foundation, The MathWorks, Microsoft Research, the Gates Foundation, Google, One Mind Foundation, and Samsung Research. G.D.C. has financial interest in AliveCor and receives unrestricted funding from the company. He also is the CTO of MindChild Medical and CSO of LifeBell AI and has ownership in both companies. These relationships are unconnected to the current work. L.T.G. is on the scientific advisory board of the nonprofit Sage Bionetworks, for which she receives a small honorarium. S.S. has received funding from the Florida Medical Malpractice Joint Underwriter's Association Dr. Alvin E. Smith Safety of Healthcare Services Grant, Allergan Foundation, the National Institutes of Health/National Institute on Aging-funded Jacksonville Aging Studies Center (JAX-ASCENT; R33AG05654), the Substance Abuse and Mental Health Services Administration (1H79TI083101-01), and the Florida Blue Foundation. C.W.J. reports no direct conflicts related to this paper, and no ongoing conflicts. He has been an investigator on studies funded by Hologic Inc., Janssen, and AstraZeneca, for which his department has received research funding. Over the past 3 years, D.A.P. has received consulting fees from BlackThorn Therapeutics, Boehringer Ingelheim, Compass Pathway, Concert Pharmaceuticals, Engrail Therapeutics, Neurocrine Biosciences, Otsuka Pharmaceuticals, and Takeda Pharmaceuticals; one honorarium from Alkermes, and research funding from Millennium Pharmaceuticals. In addition, he has received stock options from BlackThorn Therapeutics. No funding from these entities was used to support the current work, and all views expressed are solely those of the authors. J.M.E. reports support from the National Institutes of Health through Grants R01HD079076 and R03HD094577, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Center for Medical Rehabilitation Research, and South Wales Health Spinal Cord Injury Research Grants Program. In the past 3 years, R.C.K. was a consultant for Datastat, Inc., RallyPoint Networks, Inc., Sage Pharmaceuticals, and Takeda. The remaining authors declare no competing financial interests.

  • Correspondence should be addressed to Vishnu P. Murty at Vishnu.murty{at}temple.edu

SfN exclusive license.

References

  1. ↵
    1. Abdallah CG,
    2. Wrocklage KM,
    3. Averill CL,
    4. Akiki T,
    5. Schweinsburg B,
    6. Roy A,
    7. Martini B,
    8. Soutwick SM,
    9. Krystal JH,
    10. Scott JC
    (2017) Anterior hippocampal dysconnectivity in posttraumatic stress disorder: a dimensional and multimodal approach. Transl Psychiatry 7:e1045. doi:10.1038/tp.2017.12
    OpenUrlCrossRef
  2. ↵
    1. Asok A,
    2. Kandel ER,
    3. Rayman JB
    (2019) The neurobiology of fear generalization. Front Behav Neurosci 12:329. doi:10.3389/fnbeh.2018.00329 pmid:30697153
    OpenUrlCrossRefPubMed
  3. ↵
    1. Bannerman DM,
    2. Rawlins JN,
    3. McHugh SB,
    4. Deacon RM,
    5. Yee BK,
    6. Bast T,
    7. Zhang WN,
    8. Pothuizen HH,
    9. Feldon J
    (2004) Regional dissociations within the hippocampus: memory and anxiety. Neurosci Biobehav Rev 28:273–283. doi:10.1016/j.neubiorev.2004.03.004 pmid:15225971
    OpenUrlCrossRefPubMed
  4. ↵
    1. Besnard A,
    2. Sahay A
    (2016) Adult hippocampal neurogenesis, fear generalization, and stress. Neuropsychopharmacol 41:24–44. doi:10.1038/npp.2015.167
    OpenUrlCrossRefPubMed
  5. ↵
    1. Bisby JA,
    2. Burgess N
    (2013) Negative affect impairs associative memory but not item memory. Learn Mem 21:21–27. doi:10.1101/lm.032409.113 pmid:24345636
    OpenUrlCrossRefPubMed
  6. ↵
    1. Bisby JA,
    2. Burgess N
    (2017) Differential effects of negative emotion on memory for items and associations, and their relationship to intrusive imagery. Curr Opin Behav Sci 17:124–132. doi:10.1016/j.cobeha.2017.07.012 pmid:29238740
    OpenUrlCrossRefPubMed
  7. ↵
    1. Bremner JD
    (2001) Hypotheses and controversies related to effects of stress on the hippocampus: an argument for stress-induced damage to the hippocampus in patients with posttraumatic stress disorder. Hippocampus 11:75–81. doi:10.1002/hipo.1023 pmid:11345127
    OpenUrlCrossRefPubMed
  8. ↵
    1. Bremner JD
    (2006) The relationship between cognitive and brain changes in posttraumatic stress disorder. Ann N Y Acad Sci 1071:80–86.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Bremner J,
    2. Vythilingam M,
    3. Vermetten E,
    4. Southwick SM,
    5. Mcglashan T,
    6. Staib LH,
    7. Soufer R,
    8. Charney DS
    (2003) Neural correlates of declarative memory for emotionally valenced words in women with posttraumatic stress disorder related to early childhood sexual abuse. Biol Psychiatry 53:879–889. doi:10.1016/s0006-3223(02)01891-7 pmid:12742675
    OpenUrlCrossRefPubMed
  10. ↵
    1. Briscione MA,
    2. Jovanovic T,
    3. Norrholm SD
    (2014) Conditioned fear associated phenotypes as robust, translational indices of trauma-, stressor-, and anxiety-related behaviors. Front Psychiatry 5:88. doi:10.3389/fpsyt.2014.00088 pmid:25101010
    OpenUrlCrossRefPubMed
  11. ↵
    1. Cacciaglia R,
    2. Nees F,
    3. Grimm O,
    4. Ridder S,
    5. Pohlack ST,
    6. Diener SJ,
    7. Liebscher C,
    8. Flor H
    (2017) Trauma exposure relates to heightened stress, altered amygdala morphology and deficient extinction learning: implications for psychopathology. Psychoneuroendocrinology 76:19–28. doi:10.1016/j.psyneuen.2016.11.012 pmid:27871027
    OpenUrlCrossRefPubMed
  12. ↵
    1. Clewett D,
    2. Murty VP
    (2019) Echoes of emotions past: how neuromodulators determine what we recollect. eNeuro 6:ENEURO.0108-18.2019–19. doi:10.1523/ENEURO.0108-18.2019
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Delgado MR,
    2. Nystrom LE,
    3. Fissell C,
    4. Noll DC,
    5. Fiez JA
    (2000) Tracking the hemodynamic responses to reward and punishment in the striatum. J Neurophysiol 84:3072–3077. doi:10.1152/jn.2000.84.6.3072 pmid:11110834
    OpenUrlCrossRefPubMed
  14. ↵
    1. Desikan RS,
    2. Ségonne F,
    3. Fischl B,
    4. Quinn BT,
    5. Dickerson BC,
    6. Blacker D,
    7. Buckner RL,
    8. Dale AM,
    9. Maguire RP,
    10. Hyman BT,
    11. Albert MS,
    12. Killiany RJ
    (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968–980. doi:10.1016/j.neuroimage.2006.01.021 pmid:16530430
    OpenUrlCrossRefPubMed
  15. ↵
    1. Dickie EW,
    2. Brunet A,
    3. Akerib V,
    4. Armony JL
    (2011) Neural correlates of recovery from post-traumatic stress disorder: a longitudinal fMRI investigation of memory encoding. Neuropsychologia 49:1771–1778. doi:10.1016/j.neuropsychologia.2011.02.055 pmid:21382385
    OpenUrlCrossRefPubMed
  16. ↵
    1. Dolcos F,
    2. LaBar KS,
    3. Cabeza R
    (2004) Interaction between the amygdala and the medial temporal lobe memory system predicts better memory for emotional events. Neuron 42:855–863. doi:10.1016/s0896-6273(04)00289-2 pmid:15182723
    OpenUrlCrossRefPubMed
  17. ↵
    1. Eichenbaum H
    (2001) The hippocampus and declarative memory: cognitive mechanisms and neural codes. Behav Brain Res 127:199–207. doi:10.1016/s0166-4328(01)00365-5 pmid:11718892
    OpenUrlCrossRefPubMed
  18. ↵
    1. Ekman P,
    2. Friesen WV
    (1976) Measuring facial movement. J Nonverbal Behav 1:56–75. doi:10.1007/BF01115465
    OpenUrlCrossRef
  19. ↵
    1. Esteban O,
    2. Birman D,
    3. Schaer M,
    4. Koyejo O,
    5. Poldrack RA,
    6. Gorgolewski KJ
    (2017) MRIQC: advancing the automatic prediction of image quality in MRI from unseen sites. PLoS One 12:e0184661. doi:10.1371/journal.pone.0184661 pmid:28945803
    OpenUrlCrossRefPubMed
  20. ↵
    1. Glover EM,
    2. Phifer JE,
    3. Crain DF,
    4. Norrholm SD,
    5. Davis M,
    6. Bradley B,
    7. Ressler KJ,
    8. Jovanovic T
    (2011) Tools for translational neuroscience: PTSD is associated with heightened fear responses using acoustic startle but not skin conductance measures. Depress Anxiety 28:1058–1066. doi:10.1002/da.20880 pmid:21898707
    OpenUrlCrossRefPubMed
  21. ↵
    1. Goldfarb EV,
    2. Rosenberg MD,
    3. Seo D,
    4. Constable RT,
    5. Sinha R
    (2020) Hippocampal seed connectome-based modeling predicts the feeling of stress. Nat Commun 11:2650. doi:10.1038/s41467-020-16492-2 pmid:32461583
    OpenUrlCrossRefPubMed
  22. ↵
    1. Grillon C,
    2. Baas J
    (2003) A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol 114:1557–1579. doi:10.1016/s1388-2457(03)00202-5 pmid:12948786
    OpenUrlCrossRefPubMed
  23. ↵
    1. Grillon C,
    2. Morgan CA
    (1999) Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Abnorm Psychol 108:134–142. doi:10.1037//0021-843x.108.1.134 pmid:10066999
    OpenUrlCrossRefPubMed
  24. ↵
    1. Hayes JP,
    2. LaBar KS,
    3. McCarthy G,
    4. Selgrade E,
    5. Nasser J,
    6. Dolcos F,
    7. Morey RA
    , VISN 6 Mid-Atlantic MIRECC Workgroup (2011) Reduced hippocampal and amygdala activity predicts memory distortions for trauma reminders in combat-related PTSD. J Psychiatr Res 45:660–669. doi:10.1016/j.jpsychires.2010.10.007 pmid:21047644
    OpenUrlCrossRefPubMed
  25. ↵
    1. Henckens MJ,
    2. Hermans EJ,
    3. Pu Z,
    4. Joëls M,
    5. Fernández G
    (2009) Stressed memories: how acute stress affects memory formation in humans. J Neurosci 29:10111–10119. doi:10.1523/JNEUROSCI.1184-09.2009 pmid:19675245
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Herman JP,
    2. McKlveen JM,
    3. Ghosal S,
    4. Kopp B,
    5. Wulsin A,
    6. Makinson R,
    7. Scheimann J,
    8. Myers B
    (2016) Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol 6:603–621. doi:10.1002/cphy.c150015 pmid:27065163
    OpenUrlCrossRefPubMed
  27. ↵
    1. Hoffmann AN,
    2. Lorson NG,
    3. Sanabria F,
    4. Olive MF,
    5. Conrad CD
    (2014) Chronic stress disrupts fear extinction and enhances amygdala and hippocampal Fos expression in an animal model of post-traumatic stress disorder. Neurobiol Learn Mem 112:139–147.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Insel T,
    2. Cuthbert B,
    3. Garvey M,
    4. Heinssen R,
    5. Pine DS,
    6. Quinn K,
    7. Sanislow C,
    8. Wang P
    (2010) Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 167:748–751. doi:10.1176/appi.ajp.2010.09091379 pmid:20595427
    OpenUrlCrossRefPubMed
  29. ↵
    1. Jenkinson M,
    2. Beckmann CF,
    3. Behrens TE,
    4. Woolrich MW,
    5. Smith SM
    (2012) FSL. Neuroimage 62:782–790. doi:10.1016/j.neuroimage.2011.09.015 pmid:21979382
    OpenUrlCrossRefPubMed
  30. ↵
    1. Jimenez JC,
    2. Su K,
    3. Goldberg AR,
    4. Luna VM,
    5. Biane JS,
    6. Ordek G,
    7. Zhou P,
    8. Ong SK,
    9. Wright MA,
    10. Zweifel L,
    11. Paninski L,
    12. Hen R,
    13. Kheirbek MA
    (2018) Anxiety cells in a hippocampal-hypothalamic circuit. Neuron 97:670–683. doi:10.1016/j.neuron.2018.01.016 pmid:29397273
    OpenUrlCrossRefPubMed
  31. ↵
    1. Joëls M,
    2. Pu Z,
    3. Wiegert O,
    4. Oitzl MS,
    5. Krugers HJ
    (2006) Learning under stress: how does it work? Trends Cogn Sci 10:152–158. doi:10.1016/j.tics.2006.02.002 pmid:16513410
    OpenUrlCrossRefPubMed
  32. ↵
    1. Jovanovic T,
    2. Keyes M,
    3. Fiallos A,
    4. Myers KM,
    5. Davis M,
    6. Duncan EJ
    (2005) Fear potentiation and fear inhibition in a human fear-potentiated startle paradigm. Biol Psychiatry 57:1559–1564.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Jovanovic T,
    2. Norrholm SD,
    3. Blanding NQ,
    4. Davis M,
    5. Duncan E,
    6. Bradley B,
    7. Ressler KJ
    (2010) Impaired fear inhibition is a biomarker of PTSD but not depression. Depress Anxiety 27:244–251. doi:10.1002/da.20663 pmid:20143428
    OpenUrlCrossRefPubMed
  34. ↵
    1. Jovanovic T,
    2. Kazama A,
    3. Bachevalier J,
    4. Davis M
    (2012) Impaired safety signal learning may be a biomarker of PTSD. Neuropharmacology 62:695–704. doi:10.1016/j.neuropharm.2011.02.023 pmid:21377482
    OpenUrlCrossRefPubMed
  35. ↵
    1. Jovanovic T,
    2. Ely T,
    3. Fani N,
    4. Glover EM,
    5. Gutman D,
    6. Tone EB,
    7. Norrholm SD,
    8. Bradley B,
    9. Ressler KJ
    (2013) Reduced neural activation during an inhibition task is associated with impaired fear inhibition in a traumatized civilian sample. Cortex 49:1884–1891. doi:10.1016/j.cortex.2012.08.011 pmid:23020899
    OpenUrlCrossRefPubMed
  36. ↵
    1. Kerr KM,
    2. Agster KL,
    3. Furtak SC,
    4. Burwell RD
    (2007) Functional neuroanatomy of the parahippocampal region: the lateral and medial entorhinal areas. Hippocampus 17:697–708. doi:10.1002/hipo.20315 pmid:17607757
    OpenUrlCrossRefPubMed
  37. ↵
    1. Kim JJ,
    2. Diamond DM
    (2002) The stressed hippocampus, synaptic plasticity and lost memories. Nat Rev Neurosci 3:453–462. doi:10.1038/nrn849 pmid:12042880
    OpenUrlCrossRefPubMed
  38. ↵
    1. Kim YJ,
    2. van Rooij SJ,
    3. Ely TD,
    4. Fani N,
    5. Ressler KJ,
    6. Jovanovic T,
    7. Stevens JS
    (2019) Association between posttraumatic stress disorder severity and amygdala habituation to fearful stimuli. Depress Anxiety 36:647–658. doi:10.1002/da.22928 pmid:31260599
    OpenUrlCrossRefPubMed
  39. ↵
    1. Kjelstrup KG,
    2. Tuvnes FA,
    3. Steffenach HA,
    4. Murison R,
    5. Moser EI,
    6. Moser MB
    (2002) Reduced fear expression after lesions of the ventral hippocampus. Proc Natl Acad Sci USA 99:10825–10830. doi:10.1073/pnas.152112399 pmid:12149439
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Lazarov A,
    2. Zhu X,
    3. Suarez-Jimenez B,
    4. Rutherford BR,
    5. Neria Y
    (2017) Resting-state functional connectivity of anterior and posterior hippocampus in posttraumatic stress disorder. J Psychiatr Res 94:15–22. doi:10.1016/j.jpsychires.2017.06.003 pmid:28633076
    OpenUrlCrossRefPubMed
  41. ↵
    1. Li X,
    2. Morgan PS,
    3. Ashburner J,
    4. Smith J,
    5. Rorden C
    (2016) The first step for neuroimaging data analysis: DICOM to NIfTI conversion. J Neurosci Methods 264:47–56. doi:10.1016/j.jneumeth.2016.03.001 pmid:26945974
    OpenUrlCrossRefPubMed
  42. ↵
    1. Maeng LY,
    2. Milad MR
    (2017) Post-traumatic stress disorder: the relationship between the fear response and chronic stress. Chronic Stress (Thousand Oaks) 1:2470547017713297. doi:10.1177/2470547017713297 pmid:32440579
    OpenUrlCrossRefPubMed
  43. ↵
    1. Maren S,
    2. Holmes A
    (2016) Stress and fear extinction. Neuropsychopharmacology 41:58–79. doi:10.1038/npp.2015.180 pmid:26105142
    OpenUrlCrossRefPubMed
  44. ↵
    1. McEwen BS
    (2007) Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 87:873–904. doi:10.1152/physrev.00041.2006 pmid:17615391
    OpenUrlCrossRefPubMed
  45. ↵
    1. McLean SA, et al
    . (2020) The AURORA Study: a longitudinal, multimodal library of brain biology and function after traumatic stress exposure. Mol Psychiatry 25:283–296. doi:10.1038/s41380-019-0581-3 pmid:31745239
    OpenUrlCrossRefPubMed
  46. ↵
    1. Milad MR,
    2. Pitman RK,
    3. Ellis CB,
    4. Gold AL,
    5. Shin LM,
    6. Lasko NB,
    7. Zeidan MA,
    8. Handwerger K,
    9. Orr SP,
    10. Rauch SL
    (2009) Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder. Biol Psychiatry 66:1075–1082. doi:10.1016/j.biopsych.2009.06.026 pmid:19748076
    OpenUrlCrossRefPubMed
  47. ↵
    1. Murty VP,
    2. Adcock RA
    (2017) Motivated memory: anticipated reward and punishment shape encoding via differential medial temporal network recruitment. In: The hippocampus from cells to systems (Hannula D, Duff M, eds), pp 467–501. New York: Springer.
  48. ↵
    1. Murty VP,
    2. Ritchey M,
    3. Adcock RA,
    4. LaBar KS
    (2010) fMRI studies of successful emotional memory encoding: a quantitative meta-analysis. Neuropsychologia 48:3459–3469. doi:10.1016/j.neuropsychologia.2010.07.030 pmid:20688087
    OpenUrlCrossRefPubMed
  49. ↵
    1. Murty VP,
    2. Tompary A,
    3. Adcock RA,
    4. Davachi L
    (2017) Selectivity in postencoding connectivity with high-level visual cortex is associated with reward-motivated memory. J Neurosci 37:537–545. doi:10.1523/JNEUROSCI.4032-15.2016 pmid:28100737
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Murty VP,
    2. Shah H,
    3. Montez D,
    4. Foran W,
    5. Calabro F,
    6. Luna B
    (2018) Age-related trajectories of functional coupling between the VTA and nucleus accumbens depend on motivational state. J Neurosci 38:7420–7427. doi:10.1523/JNEUROSCI.3508-17.2018 pmid:30030394
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. Norrholm SD,
    2. Jovanovic T
    (2018) Fear processing, psychophysiology, and PTSD. Harv Rev Psychiatry 26:129–141. doi:10.1097/HRP.0000000000000189 pmid:29734227
    OpenUrlCrossRefPubMed
  52. ↵
    1. Norrholm SD,
    2. Jovanovic T,
    3. Olin IW,
    4. Sands LA,
    5. Karapanou I,
    6. Bradley B,
    7. Ressler KJ
    (2011) Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity. Biol Psychiatry 69:556–563. doi:10.1016/j.biopsych.2010.09.013 pmid:21035787
    OpenUrlCrossRefPubMed
    1. Pitman RK,
    2. Gilbertson MW,
    3. Gurvits TV,
    4. May FS,
    5. Lasko NB,
    6. Metzger LJ,
    7. Shenton ME,
    8. Yehuda R,
    9. Orr SP
    , Harvard/VA PTSD Twin Study Investigators (2006) Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Ann NY Acad Sci 1071:242–254. doi:10.1196/annals.1364.019 pmid:16891575
    OpenUrlCrossRefPubMed
  53. ↵
    1. Pitman RK,
    2. Rasmusson AM,
    3. Koenen KC,
    4. Shin LM,
    5. Orr SP,
    6. Gilbertson MW,
    7. Milad MR,
    8. Liberzon I
    (2012) Biological studies of post-traumatic stress disorder. Nat Rev Neurosci 13:769–787. doi:10.1038/nrn3339 pmid:23047775
    OpenUrlCrossRefPubMed
  54. ↵
    1. Poppenk J,
    2. Evensmoen HR,
    3. Moscovitch M,
    4. Nadel L
    (2013) Long-axis specialization of the human hippocampus. Trends Cogn Sci 17:230–240. doi:10.1016/j.tics.2013.03.005 pmid:23597720
    OpenUrlCrossRefPubMed
  55. ↵
    1. Schwabe L,
    2. Wolf OT
    (2012) Stress modulates the engagement of multiple memory systems in classification learning. J Neurosci 32:11042–11049. doi:10.1523/JNEUROSCI.1484-12.2012 pmid:22875937
    OpenUrlAbstract/FREE Full Text
  56. ↵
    1. Shin LM,
    2. Liberzon I
    (2010) The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35:169–191. doi:10.1038/npp.2009.83
    OpenUrlCrossRefPubMed
  57. ↵
    1. Shin LM,
    2. Wright CI,
    3. Cannistraro PA,
    4. Wedig MM,
    5. McMullin K,
    6. Martis B,
    7. Macklin ML,
    8. Lasko NB,
    9. Cavanagh SR,
    10. Krangel TS,
    11. Orr SP,
    12. Pitman RK,
    13. Whalen PJ,
    14. Rauch SL
    (2005) A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry 62:273–281. doi:10.1001/archpsyc.62.3.273 pmid:15753240
    OpenUrlCrossRefPubMed
  58. ↵
    1. Stevens JS,
    2. Jovanovic T,
    3. Fani N,
    4. Ely TD,
    5. Glover EM,
    6. Bradley B,
    7. Ressler KJ
    (2013) Disrupted amygdala-prefrontal functional connectivity in civilian women with posttraumatic stress disorder. J Psychiatric Res 47:1469–1478. doi:10.1016/j.jpsychires.2013.05.031
    OpenUrlCrossRefPubMed
  59. ↵
    1. Strange BA,
    2. Twitter MP,
    3. Lein ED,
    4. Moser EI
    (2014) Functional organization of the hippocampal longitudinal axis. Nat Rev Neurosci 15:655–669. doi:10.1038/nrn3785 pmid:25234264
    OpenUrlCrossRefPubMed
  60. ↵
    1. Tural Ü,
    2. Aker AT,
    3. Önder E,
    4. Sodan HT,
    5. Ünver H,
    6. Akansel G
    (2018) Neurotrophic factors and hippocampal activity in PTSD. PLoS One 13:e0197889. doi:10.1371/journal.pone.0197889 pmid:29799860
    OpenUrlCrossRefPubMed
  61. ↵
    1. van Rooij SJ,
    2. Jovanovic T
    (2019) Impaired inhibition as an intermediate phenotype for PTSD risk and treatment response. Prog Neuropsychopharmacol Biol Psychiatry 89:435–445. doi:10.1016/j.pnpbp.2018.10.014 pmid:30381236
    OpenUrlCrossRefPubMed
  62. ↵
    1. van Rooij SJ,
    2. Stevens JS,
    3. Ely TD,
    4. Fani N,
    5. Smith AK,
    6. Kerley KA,
    7. Lori A,
    8. Ressler KJ,
    9. Jovanovic T
    (2016) Childhood trauma and COMT genotype interact to increase hippocampal activation in resilient individuals. Front Psychiatry 7:156. pmid:27683563
    OpenUrlPubMed
  63. ↵
    1. van Rooij SJ,
    2. Stevens JS,
    3. Ely TD,
    4. Hinrichs R,
    5. Michopoulos V,
    6. Winters SJ,
    7. Ogbonmwan YE,
    8. Shin J,
    9. Nugent NR,
    10. Hudak LA,
    11. Rothbaum BO,
    12. Ressler KJ,
    13. Jovanovic T
    (2018) The role of the hippocampus in predicting future posttraumatic stress disorder symptoms in recently traumatized civilians. Biol Psychiatry 84:106–115. doi:10.1016/j.biopsych.2017.09.005 pmid:29110899
    OpenUrlCrossRefPubMed
  64. ↵
    1. van Rooij SJ,
    2. Ravi M,
    3. Ely TD,
    4. Michopoulos V,
    5. Winters SJ,
    6. Shin J,
    7. Marin MF,
    8. Milad MR,
    9. Rothbaum BO,
    10. Ressler KJ,
    11. Jovanovic T,
    12. Stevens JS
    (2021) Hippocampal activation during contextual fear inhibition related to resilience in the early aftermath of trauma. Behav Brain Res 408:113282. doi:10.1016/j.bbr.2021.113282 pmid:33819532
    OpenUrlCrossRefPubMed
  65. ↵
    1. Walker D,
    2. Davis M
    (2002) Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology (Berl) 164:318–328. doi:10.1007/s00213-002-1213-0 pmid:12424556
    OpenUrlCrossRefPubMed
  66. ↵
    1. Weathers FW,
    2. Litz BT,
    3. Keane TM,
    4. Palmieri PA,
    5. Marx BP,
    6. Schnurr PP
    (2013) The PTSD Checklist for DSM-5 (PCL-5) – Standard [Measurement Instrument]. National Center for PTSD.
  67. ↵
    1. Yehuda R,
    2. Teicher MH,
    3. Trestman RL,
    4. Levengood RA,
    5. Siever LJ
    (1996) Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 40:79–88. doi:10.1016/0006-3223(95)00451-3 pmid:8793040
    OpenUrlCrossRefPubMed
Back to top

In this issue

The Journal of Neuroscience: 42 (34)
Journal of Neuroscience
Vol. 42, Issue 34
24 Aug 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Hippocampal Threat Reactivity Interacts with Physiological Arousal to Predict PTSD Symptoms
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Hippocampal Threat Reactivity Interacts with Physiological Arousal to Predict PTSD Symptoms
Büşra Tanriverdi, David F. Gregory, Thomas M. Olino, Timothy D. Ely, Nathaniel G. Harnett, Sanne J.H. van Rooij, Lauren A.M. Lebois, Antonia V. Seligowski, Tanja Jovanovic, Kerry J. Ressler, Stacey L. House, Francesca L. Beaudoin, Xinming An, Thomas C. Neylan, Gari D. Clifford, Sarah D. Linnstaedt, Laura T. Germine, Kenneth A. Bollen, Scott L. Rauch, John P. Haran, Alan B. Storrow, Christopher Lewandowski, Paul I. Musey, Phyllis L. Hendry, Sophia Sheikh, Christopher W. Jones, Brittany E. Punches, Michael C. Kurz, Meghan E. McGrath, Lauren A. Hudak, Jose L. Pascual, Mark J. Seamon, Elizabeth M. Datner, Claire Pearson, Robert M. Domeier, Niels K. Rathlev, Brian J. O'Neil, Leon D. Sanchez, Steven E. Bruce, Mark W. Miller, Robert H. Pietrzak, Jutta Joormann, Deanna M. Barch, Diego A. Pizzagalli, John F. Sheridan, Jordan W. Smoller, Steven E. Harte, James M. Elliott, Samuel A. McLean, Ronald C. Kessler, Karestan C. Koenen, Jennifer S. Stevens, Vishnu P. Murty
Journal of Neuroscience 24 August 2022, 42 (34) 6593-6604; DOI: 10.1523/JNEUROSCI.0911-21.2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Hippocampal Threat Reactivity Interacts with Physiological Arousal to Predict PTSD Symptoms
Büşra Tanriverdi, David F. Gregory, Thomas M. Olino, Timothy D. Ely, Nathaniel G. Harnett, Sanne J.H. van Rooij, Lauren A.M. Lebois, Antonia V. Seligowski, Tanja Jovanovic, Kerry J. Ressler, Stacey L. House, Francesca L. Beaudoin, Xinming An, Thomas C. Neylan, Gari D. Clifford, Sarah D. Linnstaedt, Laura T. Germine, Kenneth A. Bollen, Scott L. Rauch, John P. Haran, Alan B. Storrow, Christopher Lewandowski, Paul I. Musey, Phyllis L. Hendry, Sophia Sheikh, Christopher W. Jones, Brittany E. Punches, Michael C. Kurz, Meghan E. McGrath, Lauren A. Hudak, Jose L. Pascual, Mark J. Seamon, Elizabeth M. Datner, Claire Pearson, Robert M. Domeier, Niels K. Rathlev, Brian J. O'Neil, Leon D. Sanchez, Steven E. Bruce, Mark W. Miller, Robert H. Pietrzak, Jutta Joormann, Deanna M. Barch, Diego A. Pizzagalli, John F. Sheridan, Jordan W. Smoller, Steven E. Harte, James M. Elliott, Samuel A. McLean, Ronald C. Kessler, Karestan C. Koenen, Jennifer S. Stevens, Vishnu P. Murty
Journal of Neuroscience 24 August 2022, 42 (34) 6593-6604; DOI: 10.1523/JNEUROSCI.0911-21.2022
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • arousal
  • fear
  • fMRI
  • hippocampus
  • trauma

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Articles

  • The human centromedial amygdala contributes to negative prediction error signaling during appetitive and aversive Pavlovian gustatory learning
  • Perceptual Difficulty Regulates Attentional Gain Modulations in Human Visual Cortex
  • Concurrent- and after-effects of medial temporal lobe stimulation on directed information flow to and from prefrontal and parietal cortices during memory formation
Show more Research Articles

Behavioral/Cognitive

  • The human centromedial amygdala contributes to negative prediction error signaling during appetitive and aversive Pavlovian gustatory learning
  • Perceptual Difficulty Regulates Attentional Gain Modulations in Human Visual Cortex
  • Concurrent- and after-effects of medial temporal lobe stimulation on directed information flow to and from prefrontal and parietal cortices during memory formation
Show more Behavioral/Cognitive
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.